Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

FDA Expand Booster Eligibility, Pfizer Seeks Emergency Approval of COVID-19 Antiviral Drug

The U.S. Food and Drug Administration this week expanded the eligibility criteria to receive a COVID-19 vaccine booster shot.

The agency has now authorized a single booster dose for all individuals 18 years of age and older who have been fully vaccinated previously with any FDA-authorized or approved COVID-19 vaccine.

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

US CDC, FDA Authorize Pfizer Vaccine Booster Shots For Elderly, At-Risk Populations

The U.S. Food and Drug Administration this week amended its emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to allow for a single booster dose, to be administered at least six months after completion of the primary series in:

  • individuals 65 years of age and older;
  • individuals 18 through 64…

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

COVID-19 Antiviral Drug Approved In UK, Global Death Toll Crosses 5 Million Mark

The United Kingdom’s Medicines and Health products Regulatory Agency this week greenlit the use of Merck’s Lagevrio (molnupiravir) antiviral drug in the country, making it the first COVID-19 oral antiviral to be approved anywhere in the world.

The pill “is safe and effective at reducing the risk of hospitalisation and…

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

FDA Approves More COVID At-Home Tests, Merck Licenses Anti-viral Drug

The U.S. Food and Drug Administration this week authorized the 10th and 11th over-the-counter COVID-19 test, and reissued the emergency use authorization for another OTC COVID-19 test.

The FDA Issued an EUA for the Celltrion DiaTrust COVID-19 Ag Home Test, an OTC COVID-19 diagnostic antigen test. The test can be…

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

Moderna, J&J COVID-19 Vaccine Boosters Approved, Prep Begins For Vaccinating Kids

The U.S. Food and Drug Administration advisory panel this week announced it is approving booster shots of Moderna and Johnson & Johnson’s COVID-19 vaccines.

The FDA amended the emergency use authorizations for Moderna’s vaccine to allow a single booster administered at least six months after the initial two jabs for…

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

Ramping Up Availability Of At-Home Rapid COVID Tests

The U.S. Food and Drug Administration this week granted an emergency use authorization (EUA) to ACON Laboratories Flowflex COVID-19 Home Test, an over-the-counter antigen test that can now be used at home without a prescription.

“Today’s authorization for the ACON Laboratories Flowflex COVID-19 Home Test should significantly increase the availability…

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

Merck To Seek Authorization For COVID Antiviral Pill

Pharmaceutical giant Merck announced this week that molnupiravir, its oral antiviral medicine, significantly reduced the risk of hospitalization or death in at-risk, non-hospitalized adult patients with mild-to-moderate COVID-19.

The company said molnupiravir reduced the risk of hospitalization or death by approximately 50%, and that through Day 29, no deaths were…

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

EU’s CDC Says No ‘Urgent Need’ For COVID-19 Vaccine Boosters

The European Union’s Centre for Disease Prevention and Control published a report this week with results from a study that concluded fully-vaccinated individuals — who are not immunocompromised — do not need another vaccine shot.

The report made the distinction between “booster” doses for people who responded adequately to primary…

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

FDA Issues First Approval of A COVID-19 Vaccine

The U.S. Food and Drug Administration this week issued its first approval of a COVID-19 vaccine, granting full authorization to Pfizer’s drug.

The vaccine will now be marketed as Comirnaty, for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be…

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

Biden Administration Ramps Up Efforts To Increase Vaccinations

As the number of COVID-19 cases, hospitalizations and deaths have surged in the past month, the U.S. government this week shifted its drive to get more Americans protected against the worst effects of COVID-19 into high gear.

The highlight of that effort was the announcement that all those who have…

Brai Odion-Esene

Founder — SW4 Insights. Public policy junkie and Central Bank Watcher. Recovering journalist and former Senior Director at Hamilton Place Strategies

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store